Pinacidil

This classification denotes an antihypertensive agent with the molecular formula C13H19N5.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7B0ZZH8P2W, chemically known as 2-cyano-3-(4-pyridinyl)-1-(1,2,2-trimethylpropyl)guanidine but generally known as pinacidil, which bears US NIH Compound Identifier 4826. European Medicines Agency schedules Pinacidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09848MIG. World Health Organization schedules pinacidil in its Anatomical Therapeutic Chemical (ATC) Classification. PINACIDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pinacidil under HS 29333999 and SITC 51574. As of Q4 2014, PINACIDIL remains the US FDA Preferred Term for this commodity. Pinacidil bears US NLM identifiers UMLS ID C0071074 and NCI Concept Code C66387. SMILES: N(=C(\Nc1ccncc1)NC#N)/C(C(C)(C)C)C.